304 related articles for article (PubMed ID: 25907249)
1. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.
Bridler R; Häberle A; Müller ST; Cattapan K; Grohmann R; Toto S; Kasper S; Greil W
Eur Neuropsychopharmacol; 2015 Jun; 25(6):763-72. PubMed ID: 25907249
[TBL] [Abstract][Full Text] [Related]
2. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.
Pascual JC; Martín-Blanco A; Soler J; Ferrer A; Tiana T; Alvarez E; Pérez V
Int Clin Psychopharmacol; 2010 Nov; 25(6):349-55. PubMed ID: 20838221
[TBL] [Abstract][Full Text] [Related]
3. Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines.
Riffer F; Farkas M; Streibl L; Kaiser E; Sprung M
Int J Psychiatry Clin Pract; 2019 Sep; 23(3):178-188. PubMed ID: 31140337
[No Abstract] [Full Text] [Related]
4. Borderline personality and psychotropic medication prescription in an outpatient psychiatry clinic.
Sansone RA; Rytwinski D; Gaither GA
Compr Psychiatry; 2003; 44(6):454-8. PubMed ID: 14610722
[TBL] [Abstract][Full Text] [Related]
5. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain.
Pascual JC; Martín-Blanco A; Soler J
CNS Drugs; 2021 Sep; 35(9):1023-1032. PubMed ID: 34370282
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy.
Paolini E; Mezzetti FA; Pierri F; Moretti P
Int J Psychiatry Clin Pract; 2017 Mar; 21(1):75-79. PubMed ID: 27669762
[TBL] [Abstract][Full Text] [Related]
7. [Psychopharmacotherapy in adolescents with borderline personality disorder in inpatient and outpatient psychiatric treatment].
Wöckel L; Goth K; Matic N; Zepf FD; Holtmann M; Poustka F
Z Kinder Jugendpsychiatr Psychother; 2010 Jan; 38(1):37-49. PubMed ID: 20047175
[TBL] [Abstract][Full Text] [Related]
8. Psychopharmacology for Borderline Personality Disorder.
Limandri BJ
J Psychosoc Nurs Ment Health Serv; 2018 Apr; 56(4):8-11. PubMed ID: 29596715
[TBL] [Abstract][Full Text] [Related]
9. Prescribing Practices for Patients With Borderline Personality Disorder During Psychiatric Hospitalizations.
Romanowicz M; Schak KM; Vande Voort JL; Leung JG; Larrabee BR; Palmer BA
J Pers Disord; 2020 Dec; 34(6):736-749. PubMed ID: 30742548
[TBL] [Abstract][Full Text] [Related]
10. Changes over the last 15 years in the psychopharmacological management of persons with borderline personality disorder.
Martín-Blanco A; Ancochea A; Soler J; Elices M; Carmona C; Pascual JC
Acta Psychiatr Scand; 2017 Sep; 136(3):323-331. PubMed ID: 28669135
[TBL] [Abstract][Full Text] [Related]
11. National trends in psychotropic medication polypharmacy in office-based psychiatry.
Mojtabai R; Olfson M
Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of borderline personality disorder: what has changed over two decades? A retrospective evaluation of clinical practice.
Timäus C; Meiser M; Bandelow B; Engel KR; Paschke AM; Wiltfang J; Wedekind D
BMC Psychiatry; 2019 Dec; 19(1):393. PubMed ID: 31830934
[TBL] [Abstract][Full Text] [Related]
14. Overdose and off-label psychotropic prescribing in patients with borderline personality disorder: A retrospective series.
Ning AY; Theodoros T; Harris K; Isoardi KZ
Australas Psychiatry; 2023 Apr; 31(2):195-200. PubMed ID: 36772817
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
[TBL] [Abstract][Full Text] [Related]
16. First prescription of new elderly patients attending the psychiatry outpatient of a tertiary care institute in North India.
Grover S; Kumar V; Avasthi A; Kulhara P
Geriatr Gerontol Int; 2012 Apr; 12(2):284-91. PubMed ID: 22066946
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in the treatment of borderline personality disorder.
Hilger E; Barnas C; Kasper S
World J Biol Psychiatry; 2003 Jan; 4(1):42-4. PubMed ID: 12582977
[TBL] [Abstract][Full Text] [Related]
18. [Psychopharmacotherapy improves psychosocial functioning in adolescents with borderline personality disorder].
Wöckel L; Goth K; Zepf FD; Matic N; Holtmann M; Herpertz-Dahlmann B; Poustka F
Prax Kinderpsychol Kinderpsychiatr; 2010; 59(4):282-301. PubMed ID: 20491428
[TBL] [Abstract][Full Text] [Related]
19. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Treatments for Borderline Personality Disorder: A Systematic Review and Meta-Analysis.
Gartlehner G; Crotty K; Kennedy S; Edlund MJ; Ali R; Siddiqui M; Fortman R; Wines R; Persad E; Viswanathan M
CNS Drugs; 2021 Oct; 35(10):1053-1067. PubMed ID: 34495494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
